Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05879978
Title A Study to Test How Well Different Doses of BI 764532 in Combination With Ezabenlimab Are Tolerated by People With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Boehringer Ingelheim
Age Groups: senior | adult
Covered Countries FRA | DEU | BEL

No variant requirements are available.